GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 151 filers reported holding GUARDANT HEALTH INC in Q1 2019. The put-call ratio across all filers is 1.73 and the average weighting 1.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,019,312 | +3102.9% | 607,939 | +3768.5% | 0.06% | +2700.0% |
Q2 2023 | $562,597 | -86.7% | 15,715 | -91.3% | 0.00% | -86.7% |
Q1 2023 | $4,236,733 | -26.3% | 180,748 | +26.8% | 0.02% | -37.5% |
Q2 2022 | $5,749,000 | +144.5% | 142,520 | +301.5% | 0.02% | +200.0% |
Q1 2022 | $2,351,000 | -17.5% | 35,494 | +55.7% | 0.01% | -20.0% |
Q3 2021 | $2,850,000 | -43.6% | 22,794 | -44.0% | 0.01% | -44.4% |
Q2 2021 | $5,051,000 | -35.8% | 40,672 | -21.0% | 0.02% | -48.6% |
Q1 2021 | $7,862,000 | +27.6% | 51,504 | +7.7% | 0.04% | +29.6% |
Q4 2020 | $6,161,000 | +60.3% | 47,806 | +39.0% | 0.03% | +80.0% |
Q3 2020 | $3,844,000 | +5.2% | 34,384 | -23.6% | 0.02% | -16.7% |
Q2 2020 | $3,653,000 | +1086.0% | 45,028 | +916.7% | 0.02% | +800.0% |
Q1 2020 | $308,000 | -36.9% | 4,429 | -42.0% | 0.00% | 0.0% |
Q3 2019 | $488,000 | +1.7% | 7,630 | +37.1% | 0.00% | 0.0% |
Q2 2019 | $480,000 | -27.4% | 5,564 | -35.4% | 0.00% | -33.3% |
Q1 2019 | $661,000 | – | 8,618 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |